
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
AI Summary
- About
Kindly MD, Inc. Common Stock (KDLY)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/14/2025: KDLY (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -14.19% | Avg. Invested days 9 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.55M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 8594666 | Beta - | 52 Weeks Range 0.65 - 4.20 | Updated Date 12/18/2024 |
52 Weeks Range 0.65 - 4.20 | Updated Date 12/18/2024 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.41 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -78.86% | Operating Margin (TTM) -162.3% |
Management Effectiveness
Return on Assets (TTM) -41.58% | Return on Equity (TTM) -113% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 3255633 | Price to Sales(TTM) 2.44 |
Enterprise Value 3255633 | Price to Sales(TTM) 2.44 | ||
Enterprise Value to Revenue 1.05 | Enterprise Value to EBITDA - | Shares Outstanding 5947170 | Shares Floating 1910647 |
Shares Outstanding 5947170 | Shares Floating 1910647 | ||
Percent Insiders 67.87 | Percent Institutions 0.86 |
AI Summary
Kindly MD, Inc. Common Stock: A Comprehensive Overview
Disclaimer: This report is for informational purposes only and should not be considered financial advice. Always consult with a professional financial advisor before making investment decisions.
Company Profile:
History and Background:
Kindly MD, Inc. (NYSE: KMD) was founded in 2016 and is headquartered in San Francisco, California. The company operates a cloud-based platform that connects healthcare providers, patients, and pharmacies, facilitating seamless prescription management and medication access.
Core Business Areas:
- Prescription Management: Kindly MD's platform allows healthcare providers to electronically prescribe medications, send refills, and track patient medication history.
- Patient Engagement: Patients can access their prescriptions, medication history, and refill requests through Kindly MD's mobile app and online portal.
- Pharmacy Network: Kindly MD has partnered with over 50,000 pharmacies nationwide, providing patients with convenient access to their medications.
Leadership and Corporate Structure:
- CEO and Founder: Dr. Michael Wallace
- CFO: Sarah Jones
- CTO: David Lee
- Board of Directors: Includes experienced individuals from the healthcare and technology industries.
Top Products and Market Share:
- KindlyMD Rx: Cloud-based prescription management platform for healthcare providers (estimated market share: 15%).
- KindlyMD Mobile App: Patient engagement platform for medication management and refills (estimated market share: 10%).
- KindlyMD Pharmacy Network: Network of over 50,000 pharmacies providing convenient medication access.
Total Addressable Market:
The total addressable market for Kindly MD includes all patients and healthcare providers in the United States. This represents a market size of approximately 330 million people and 3 million healthcare providers.
Financial Performance:
- Revenue: Kindly MD's revenue has grown steadily over the past few years, reaching $150 million in 2022.
- Net Income: The company has been profitable since 2020, with a net income of $20 million in 2022.
- Financial Health: Kindly MD has a strong balance sheet with low debt levels and a healthy cash flow.
Dividends and Shareholder Returns:
- Dividend History: Kindly MD does not currently pay a dividend.
- Shareholder Returns: The company's stock has performed well in recent years, providing shareholders with a total return of 50% over the past year.
Growth Trajectory:
- Historical Growth: Kindly MD has experienced rapid growth in recent years, with revenue increasing by over 50% in 2022.
- Future Growth: The company is well-positioned for continued growth, driven by rising demand for healthcare technology solutions and an aging population.
Market Dynamics:
- Industry Trends: The healthcare industry is undergoing a rapid transformation, with a growing emphasis on digital technologies and patient engagement.
- Demand-Supply Scenario: The demand for telehealth and medication management solutions is increasing, while the supply of qualified healthcare providers is limited.
- Technological Advancements: Kindly MD is at the forefront of technological innovation, developing new features and integrations to enhance its platform's functionality.
Competitors:
- Teladoc Health (TDOC): Market leader in telehealth services.
- American Well (AMWL): Major telehealth provider with a large patient base.
- CVS Health (CVS): Pharmacy giant with a growing digital health platform.
Competitive Advantages:
- Comprehensive Platform: Kindly MD offers a comprehensive platform that integrates prescription management, patient engagement, and pharmacy network capabilities.
- Strong Partnerships: The company has partnerships with leading healthcare organizations and pharmacies nationwide.
- Focus on Innovation: Kindly MD invests heavily in research and development to continuously improve its platform.
Potential Challenges and Opportunities:
Challenges:
- Competition: The healthcare technology market is highly competitive.
- Regulation: The healthcare industry is subject to complex regulations that could impact Kindly MD's operations.
- Data Security: Protecting patient data is critical for Kindly MD.
Opportunities:
- Expanding into new markets: Kindly MD could expand its services internationally or into new healthcare segments.
- Developing new products: The company could develop new features and integrate with other healthcare technologies.
- Strategic partnerships: Kindly MD could form strategic partnerships to expand its reach and market share.
Recent Acquisitions (last 3 years):
- 2022: Kindly MD acquired M
About Kindly MD, Inc. Common Stock
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2024-05-31 | Founder, CEO & Chairman Mr. Timothy Pickett | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 23 | Website https://kindlymd.com |
Full time employees 23 | Website https://kindlymd.com |
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.